InMed Pharmaceuticals (INM) Shares Outstanding (2019 - 2026)
InMed Pharmaceuticals (INM) posted quarterly Shares Outstanding (Entity) of $3.3 million for Q1 2026, up 174.53% year-over-year from $1.2 million in Q1 2025, and down 16.2% quarter-over-quarter from $4.0 million in Q4 2025.
InMed Pharmaceuticals (INM) Shares Outstanding (2019 - 2026) Analysis & Trends
InMed Pharmaceuticals' Shares Outstanding (Entity) history runs 8 years deep, the most recent figure standing at $3.3 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 174.53% year-over-year to $3.3 million; the TTM figure through Mar 2026 stood at $3.3 million (up 174.53% YoY), while the FY2025 annual figure was $975985.0, up 118.88% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $3.3 million, down from $4.0 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $4.0 million in Q3 2025, with the low at $28568.0 in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $445908.0 (2024), against an average of $988205.4.
- The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) jumped 77.43% in 2022, then surged 492.91% in 2025.
- InMed Pharmaceuticals' Shares Outstanding (Entity) stood at $115026.0 in 2022, then surged by 246.59% to $398673.0 in 2023, then surged by 81.64% to $724152.0 in 2024, then surged by 446.09% to $4.0 million in 2025, then declined by 16.2% to $3.3 million in 2026.
- Business Quant data shows INM's Shares Outstanding (Entity) at $3.3 million in Q1 2026, $4.0 million in Q4 2025, and $4.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 832.44 Mn |
| 10 | InMed Pharmaceuticals | 6.36 Mn | 1.11 Mn | - | 4.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.05 Mn |
| Dec 31, 2025 | 3.95 Mn |
| Sep 30, 2025 | 3.95 Mn |
| Jun 30, 2025 | 975,985.00 |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 706,546.00 |
| Sep 30, 2024 | 620,127.00 |
| Jun 30, 2024 | 381,054.00 |
| Mar 31, 2024 | 480,649.00 |
| Dec 31, 2023 | 398,673.00 |
| Sep 30, 2023 | 166,410.00 |
| Jun 30, 2023 | 122,423.00 |
| Mar 31, 2023 | 166,410.00 |
| Dec 31, 2022 | 115,026.00 |
| Sep 30, 2022 | 43,281.00 |
| Jun 30, 2022 | 28,041.00 |
| Mar 31, 2022 | 28,303.00 |
| Dec 31, 2021 | 27,695.00 |
| Sep 30, 2021 | 24,095.00 |
| Jun 30, 2021 | 13,440.00 |